Literature DB >> 78895

Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity.

J F Hildebrandt, L W Mayer, S P Wang, T M Buchanan.   

Abstract

Resistance to the complement-dependent bactericidal activity of normal human serum is found in nearly all Neisseria gonorrhoeae strains causing disseminated gonococcal infection. Transformation of serum-sensitive gonococcal strain NRL 7189 to serum resistance using deoxyribonucleic acid from three separate disseminated-infection gonococci was accompanied by simultaneous structural and antigenic changes in the principal outer-membrane protein (POMP) of the transformants. In each of 10 separate transformations, there was a reduction in subunit molecular weight of the POMP from that in the recipient (39,000) to that in the deoxyribonucleic acid donors (36,500). Also, in each instance the POMP antigenic type, as measured by enzyme-linked immunosorbent assay, converted from that of the recipient to an antigenic type common to each DGI donor strain. This conversion of POMP antigen was reflected in part by changes in the surface fluorescence of the transformed gonococci to the microimmunofluorescence pattern of the donor strains. These results suggested that serum resistance of gonococci is related to the possession of a POMP of characteristic subunit molecular weight and antigenicity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 78895      PMCID: PMC421582          DOI: 10.1128/iai.20.1.267-272.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Transformation of Neisseria meningitidis by deoxyribonucleates from cells and from culture slime.

Authors:  B W CATLIN
Journal:  J Bacteriol       Date:  1960-04       Impact factor: 3.490

2.  STUDIES OF GONOCOCCAL INFECTION. II. THE BACTERIOLYTIC POWER OF THE WHOLE DEFIBRINATED BLOOD OF PATIENTS WITH GONOCOCCAL ARTHRITIS.

Authors:  W W Spink; C S Keefer
Journal:  J Clin Invest       Date:  1937-03       Impact factor: 14.808

3.  Evidence for a one-hit theory in the immune bactericidal reaction and demonstration of a multi-hit response for hemolysis by streptolysin O and Clostridium perfringens theta-toxin.

Authors:  K Inoue; Y Akiyama; T Kinoshita; Y Higashi; T Amano
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

4.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

5.  Immunity to gonococcal infection induced by vaccination with isolated outer membranes of Neisseria gonorrhoeae in guinea pigs.

Authors:  T M Buchanan; R J Arko
Journal:  J Infect Dis       Date:  1977-06       Impact factor: 5.226

6.  Disseminated gonococcal infections caused by Neisseria gonorrhoeae with unique nutritional requirements.

Authors:  J S Knapp; K K Holmes
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

7.  Influence of colony type on susceptibility of gonococci to killing by human serum.

Authors:  J A McCutchan; S Levine; A I Braude
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

8.  NEISSERIA GONORRHOEAE IDENTIFICATION IN DIRECT SMEARS BY A FLUORESCENT ANTIBODY-COUNTERSTAIN METHOD.

Authors:  L A WHITE; D S KELLOGG
Journal:  Appl Microbiol       Date:  1965-03

9.  Variability of the lytic susceptibility of Neisseria gonorrhoeae to human sera.

Authors:  E C Tramont; J C Sadoff; C Wilson
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

10.  Antigenic heterogeneity of gonococcal pili.

Authors:  T M Buchanan
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  63 in total

1.  Studies on gonococcus infection. XVIII. 125I-labeled peptide mapping of the major protein of the gonococcal cell wall outer membrane.

Authors:  J Swanson
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

2.  Cell envelope alterations in antibiotic-sensitive and-resistant strains of Neisseria gonorrhoeae.

Authors:  L F Guymon; D L Walstad; P F Sparling
Journal:  J Bacteriol       Date:  1978-10       Impact factor: 3.490

3.  Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing.

Authors:  S Merino; S Camprubí; S Albertí; V J Benedí; J M Tomás
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 4.  Mucosal infection with Neisseria gonorrhoeae. Bacterial adaptation and mucosal defenses.

Authors:  M S Cohen; P F Sparling
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes.

Authors:  W Jiskoot; T Teerlink; M M Van Hoof; K Bartels; V Kanhai; D J Crommelin; E C Beuvery
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

6.  Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing.

Authors:  S Merino; X Rubires; A Aguilar; S Albertí; S Hernandez-Allés; V J Benedí; J M Tomas
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

7.  Characterization of protein I from serum-sensitive and serum-resistant transformants of Neisseria gonorrhoeae.

Authors:  R C Judd; M Tam; K Joiner
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

Review 8.  Protein I: structure, function, and genetics.

Authors:  R C Judd
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

9.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

10.  Th1 and Th2 cell involvement in immune response to Salmonella typhimurium porins.

Authors:  M Galdiero; L De Martino; A Marcatili; I Nuzzo; M Vitiello; G Cipollaro de l'Ero
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.